CaroGen Company
CaroGen develops vaccine candidates targeting hepatitis B and C, and other viral agents.
Industry:
Viral Vectors
Funding Status:
Seed
Estimated Revenue:
Less than $1M
Investors Number:
2
Headquarters:
Hamden, Connecticut, United States
Employee Number:
1-10
Total Funding:
1550000
Founded Date:
2012-01-01
Last Funding Type:
Grant
Last Funding Date:
2019-03-27